BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessEarth Science Tech, Inc. Enters $60B Pet Industry with its Nutraceutical Scientific High Grade Hemp CBD Oil Intended for Domestic AnimalsBy Nasdaq OMXFeb 16, 2017, 12:15 PM UTC
BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
